Trial Profile
Early Use of Levosimendan Compared to Usual Care in Advanced Chronic Heart Failure (ACHF).
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Levosimendan (Primary) ; Furosemide
- Indications Chronic heart failure
- Focus Therapeutic Use
- Acronyms ELEVATE
- 07 Apr 2017 Status changed from suspended to discontinued.
- 28 Mar 2017 Planned End Date changed from 1 Dec 2015 to 1 Mar 2017.
- 09 Oct 2015 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.